| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.0352028253287042 | 0.51206082 |
| NSC 726578 | Null | 0.0352028253287042 | 0.17356338 |
| NSC 731704 | 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. | 0.0352028253287042 | 0.25165385 |
| NSC 743433 | 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one | 0.0352028253287042 | 0.481745 |
| NSC 743532 | Null | 0.0352028253287042 | 0.15148572 |
| NSC 748902 | [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] | 0.0352028253287042 | 0.37713368 |
| NSC 753456 | 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole | 0.0352028253287042 | 0.16506977 |
| NSC 761822 | (Z)-3-((1-(4-fluorophenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one | 0.0352028253287042 | 0.2887432 |
| NSC 639517 | Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride | 0.0361455178924429 | 0.50912871 |
| NSC 669145 | 2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- | 0.0361455178924429 | 0.55676066 |